Article
TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
Journal of immunology (Baltimore, Md. : 1950) - 15 Aug 2011
Lask Assaf, Goichberg Polina, Cohen Adva, Goren-Arbel Rinat, Milstein Oren, Aviner Shraga, Feine Ilan, Ophir Eran, Reich-Zeliger Shlomit, Hagin David, Klein Tirza, Nagler Arnon, Berrebi Alain, Reisner Yair
Abstract excerpt
We previously demonstrated that anti-third-party CTLs (stimulated under IL-2 deprivation against cells with an MHC class I [MHC-I] background different from that of the host and the donor) are depleted of graft-versus-host reactivity and can eradicate B cell chronic lymphocytic leukemia cells in vitro or in an HU/SCID mouse model. We demonstrated in the current study that human allogeneic or autologous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
